Evidence map›Paper›PMID 40379243›Full record

ReviewThe journal of allergy and clinical immunology. In practice2025

Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence.

Ashley L Devonshire, Theresa Guilbert, Cindy S Bauer, Heidi Schmidt, Stephanie Davis, Michelle Hernandez, Anne M Fitzpatrick, Jonathan M Gaffin, Meyer Kattan, Aliva De and 13 more

Abstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ashley L DevonshireDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio. Electronic address: Ashley.Devonshire@cchmc.org.
Theresa GuilbertDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
Cindy S BauerDivision of Allergy and Immunology, Phoenix Children's, Phoenix, Ariz.
Heidi SchmidtDivision of Allergy and Immunology, Phoenix Children's, Phoenix, Ariz.
Stephanie DavisDepartment of Pediatrics, University of North Carolina, Chapel Hill, NC.
Michelle HernandezDepartment of Pediatrics, University of North Carolina, Chapel Hill, NC.
Anne M FitzpatrickDepartment of Pediatrics, Emory University, Atlanta, Ga.
Jonathan M GaffinDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, Mass.
Meyer KattanPediatric Pulmonary Division, Columbia University Irving Medical Center, New York, NY.
Aliva DePediatric Pulmonary Division, Columbia University Irving Medical Center, New York, NY.
Daniel J JacksonDepartment of Pediatrics, University of Wisconsin, Madison, Wis.
David MaugerDivision of Biostatistics, College of Medicine, Penn State University, Hershey, Pa.
Wanda PhipatanakulDivision of Allergy and Immunology, Boston Children's Hospital, Boston, Mass.
Justin T SchwartzDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
William SheehanDepartment of Pediatrics, Children's National Health System, Washington, DC.
Dayna LongDepartment of Pediatrics, University of California San Francisco Benioff Children's Hospital, Oakland, Calif.
Lourdes JuarezDepartment of Pediatrics, University of California San Francisco Benioff Children's Hospital, Oakland, Calif.
Leonard B BacharierMonroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
Jeffrey R StokesDepartment of Pediatrics, Washington University, St. Louis, Mo.
Stephen J TeachDepartment of Pediatrics, Children's National Health System, Washington, DC.
Wayne J MorganAsthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz.
Fernando D MartinezAsthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz.
ORBEX, a multicenter clinical trial network funded by the National Heart, Lung, and Blood Institute

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI George S Watts · 1994 to 2026
$36.7M
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead ApplicationU01HL130045 · NHLBI · UNIVERSITY OF ARIZONA · PI MARTINEZ, FERNANDO D · 2016 to 2020
$22.4M
NCATS NIH HHS UL1 TR001425NHLBI NIH HHS U01 HL130045NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

Multiple early life environmental exposures are thought to influence childhood asthma incidence. The coronavirus disease 2019 (COVID-19) pandemic resulted in changes in air pollution levels and a marked disruption in the circulation of childhood respiratory viruses. Both air pollution and respiratory viruses have been implicated in the development of asthma and early childhood wheeze. Human behavior and daily routine practices, including family gatherings and daycare attendance, were impacted profoundly by the COVID-19 pandemic and the associated mitigation measures. The changes to human behavior and social interactions that occurred during the pandemic have and will likely continue to impact chronic diseases, including the development of asthma. This rostrum explores how childhood asthma incidence might be affected by the COVID-19 pandemic and its associated public health mitigation measures. Recently completed and ongoing clinical trials being conducted in the infant and toddler population and assessing allergic outcomes may be well positioned to examine the impact of the pandemic on asthma incidence and time to asthma onset.

Indexed as

AsthmaCOVID-19ChildChild, PreschoolEnvironmental ExposureHumansIncidenceInfantPandemicsSARS-CoV-2AllergyAsthmaCOVID-19 pandemicMitigationPreventionRespiratory infection

Identifiers

PMID40379243
PMCPMC12409688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.